Articles
-
1 month ago |
medrxiv.org | Tran Nguyen |Robert J. Zupko |Melissa Conrad |Gerald B Rukundo
PJR consulted for GSK in 2023 and Merck in 2024 on new antimalarial drug discovery. TDN, RJZ, KTT, CCF, MFB, DMG were funded by National Institutes of Health grant NIAID R01AI153355 and Bill and Melinda Gates Foundation grant INV-005517. TDN, KTT, CCF, MFB were funded by National Institutes of Health grant NIAID R01AI153355 and Bill and Melinda Gates Foundation grant INV-056612. VA was funded by Bill and Melinda Gates Foundation grant INV-037316.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →